XML 11 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Changes in Stockholders' Deficit - USD ($)
Total
Common Stock
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Non-controlling Interest [Member]
Beginning Balance at Dec. 31, 2023 $ (85,906,534) $ 2,042 $ 263,616,186 $ (296,096,957) $ (53,427,805)
Beginning Balance, Shares at Dec. 31, 2023   20,420,896      
Share-based compensation 1,666,318 $ 1 1,666,317    
Share-based compensation, Shares   7,277      
Cancellation of stock awards for payment of withholding tax requirements (16,398)   (16,398)    
Director compensation paid in share-based instruments/Stock 246,150   246,150    
Director compensation paid in share-based instruments/stock, Shares   2,953      
Changes in ownership interest in a subsidiary 0        
Fair value of warrants classified as liabilities (7,754,438)   (7,754,438)    
Common stock issued for convertible debt conversion 1,185,734 $ 33 1,185,701    
Common stock issued for convertible debt conversion, Shares   327,456      
Common stock issued and exchanged with related party 429,569 $ 10 429,559    
Common stock issued and exchanged with related party, Shares   104,518      
Net income (loss) 13,427,676     20,659,157 (7,231,481)
Ending Balance at Sep. 30, 2024 (76,721,923) $ 2,086 259,373,077 (275,437,800) (60,659,286)
Ending Balance, Shares at Sep. 30, 2024   20,863,100      
Beginning Balance at Jun. 30, 2024 (93,917,489) $ 2,059 258,412,973 (294,126,036) (58,206,485)
Beginning Balance, Shares at Jun. 30, 2024   20,590,644      
Share-based compensation 101,785   101,785    
Common stock issued for convertible debt conversion 858,346 $ 27 858,319    
Common stock issued for convertible debt conversion, Shares   272,456      
Net income (loss) 16,235,435     18,688,236 (2,452,801)
Ending Balance at Sep. 30, 2024 (76,721,923) $ 2,086 259,373,077 (275,437,800) (60,659,286)
Ending Balance, Shares at Sep. 30, 2024   20,863,100      
Beginning Balance at Dec. 31, 2024 (79,083,171) $ 2,883 264,191,579 (280,439,023) (62,838,610)
Beginning Balance, Shares at Dec. 31, 2024   28,825,333      
Share-based compensation 137,226   137,226    
Consultant compensation paid in stock 219,495 $ 26 219,469    
Consultant compensation paid in stock, Shares   261,500      
Director compensation paid in share-based instruments/Stock 27,284 $ 5 27,279    
Director compensation paid in share-based instruments/stock, Shares   44,879      
Equity exchange in connection with Mexican corporate transactions 2,229,557   2,229,557    
Changes in ownership interest in a subsidiary 30,327,887   (30,327,887)   30,327,887
Common stock exchanged for convertible notes 15,535,615 $ 1,352 15,534,263    
Common stock exchanged for convertible notes, Shares   13,517,698      
Common stock issued for warrants exercised 1,121,685 $ 46 1,121,639    
Common stock issued for warrants exercised, Shares   460,000      
Common stock issued in connection with Securities Purchase Agreement, net of equity issuance costs 7,575,875 $ 727 7,575,148    
Common stock issued in connection with Securities Purchase Agreement, net of equity issuance costs, Shares   7,275,488      
Net income (loss) (31,063,337)     (25,679,139) (5,384,198)
Ending Balance at Sep. 30, 2025 (83,299,771) $ 5,039 260,708,273 (306,118,162) (37,894,921)
Ending Balance, Shares at Sep. 30, 2025   50,384,898      
Beginning Balance at Jun. 30, 2025 (90,265,914) $ 3,249 240,235,734 (293,045,416) (37,459,481)
Beginning Balance, Shares at Jun. 30, 2025   32,484,832      
Share-based compensation 45,742   45,742    
Consultant compensation paid in stock 71,715   71,715    
Director compensation paid in share-based instruments/Stock 10,000 $ 1 9,999    
Director compensation paid in share-based instruments/stock, Shares   8,475      
Common stock exchanged for convertible notes 15,535,615 $ 1,352 15,534,263    
Common stock exchanged for convertible notes, Shares   13,517,698      
Common stock issued in connection with Securities Purchase Agreement, net of equity issuance costs 4,811,257 $ 437 4,810,820    
Common stock issued in connection with Securities Purchase Agreement, net of equity issuance costs, Shares   4,373,893      
Net income (loss) (13,508,186)     (13,072,746) (435,440)
Ending Balance at Sep. 30, 2025 $ (83,299,771) $ 5,039 $ 260,708,273 $ (306,118,162) $ (37,894,921)
Ending Balance, Shares at Sep. 30, 2025   50,384,898